PDT Partners’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-55,918
Closed -$452K 859
2025
Q1
$452K Sell
55,918
-13,302
-19% -$145K 0.03% 543
2024
Q4
$856K Sell
69,220
-5,747
-8% -$76.7K 0.08% 373
2024
Q3
$615K Sell
74,967
-14,300
-16% -$85.5K 0.05% 463
2024
Q2
$445K Buy
89,267
+75,967
+571% +$433K 0.04% 491
2024
Q1
$82.1K Buy
+13,300
New +$66.6K 0.01% 611
2021
Q1
Sell
-130,600
Closed -$1.03M 896
2020
Q4
$1.03M Buy
130,600
+70,800
+118% +$594K 0.07% 320
2020
Q3
$508K Sell
59,800
-61
-0.1% -$669 0.03% 444
2020
Q2
$623K Sell
59,861
-58,239
-49% -$548K 0.04% 357
2020
Q1
$1.11M Buy
118,100
+62,300
+112% +$531K 0.09% 217
2019
Q4
$447K Buy
55,800
+12,000
+27% +$294K 0.03% 443
2019
Q3
$899K Sell
43,800
-7,700
-15% -$177K 0.05% 291
2019
Q2
$1.34M Buy
51,500
+28,310
+122% +$794K 0.08% 227
2019
Q1
$901K Buy
23,190
+7,090
+44% +$288K 0.05% 269
2018
Q4
$677K Sell
16,100
-5,316
-25% -$236K 0.04% 304
2018
Q3
$1.07M Sell
21,416
-16,476
-43% -$743K 0.04% 304
2018
Q2
$1.45M Sell
37,892
-7,008
-16% -$302K 0.06% 288
2018
Q1
$1.8M Buy
+44,900
New +$1.89M 0.06% 287

Other funds holding WVE

PDT Partners's WVE Position: Q2 2025 in Review

PDT Partners sold out of Wave Life Sciences (WVE) in Q2 2025, closing a stake of 55,918 shares — an estimated $452K sold.

PDT Partners first reported a position in WVE in Q1 2018 and held it in 17 quarters. The position peaked at $1.8M in Q1 2018. 176 funds tracked by Wall St. Rank hold WVE as of Q2 2025.

  • PDT Partners reported no remaining Wave Life Sciences position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 55,918 Wave Life Sciences shares in Q2 2025, an estimated $452K.
  • PDT Partners first reported a position in Wave Life Sciences in Q1 2018 and held it in 17 quarters.
  • PDT Partners's Wave Life Sciences position peaked at $1.8M in Q1 2018.
  • 176 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.